
Jason Murata is a partner in the intellectual property litigation group and chair of Axinn's Diversity, Equity & Inclusion Committee. Jason's practice involves all aspects of pre-trial, trial and appeals, with a particular focus on the pharmaceutical and biopharmaceutical, technology, consumer products, and food industries. He also brings extensive litigation experience to bear on complex issues relating to managing a company's IP risks and freedom to operate.
Professional Activities
- American Intellectual Property Law Association, Committee on the Profession
- American Bar Association, Section of Intellectual Property Law
Experience
-
Mayne Pharma Int’l Pty Ltd. v. Merck & Co., Inc., No. 15-cv-00438 (D. Del.) (patent infringement action relating to Merck’s Noxafil posaconazole products)
- Globus Medical, Inc. v. DePuy Synthes Products, LLC, No. 13-cv-00854 (D. Del.) (defend patent infringement action relating to spinal fusion implants)
-
Otsuka Pharmaceutical Co., Ltd. v. Zydus Pharmaceuticals USA Inc., Nos. 14-cv-03158-JBS-KMW & 14-cv-07252-JBS-KMW (D.N.J.) (obtained denial of motion for temporary restraining order in patent infringement action relating to generic aripiprazole drug product (Abilify))
-
Pfizer, Inc. v. Tiger Pharmaceuticals, LLC, No. 14-cv-01501-AJT-TRJ (E.D. Va.); Pfizer, Inc. v. Tiger Pharmaceuticals, LLC, No. 14-cv-08958-GHW (S.D.N.Y.); Johnson Matthey Inc. v. Pfizer, Inc., 2:15-cv-00014-AWA-TEM (E.D. Va.) (obtained dismissal of patent infringement action relating to dofetilide drug product within four months of filing of the action)
-
Depomed, Inc. v. Actavis Elizabeth LLC, No. 3:12-cv-01358 (D.N.J.) and Appeal No. 14-1828 (Fed. Cir.) (bench trial in patent infringement action relating to generic once-daily gabapentin product)
-
The Procter & Gamble Co. v. Conopco, Inc., No. 13-CV-00732-TSB (S.D. Ohio) (represented Unilever in patent infringement action relating to antidandruff shampoo products)
-
Brandeis University v. Unilever United States, Inc., No. 12-cv-01510 (N.D. Ill.) (Posner, J.) (represented Unilever in patent infringement action brought by marketer of SmartBalance products relating to margarines and buttery spreads)
-
Hospira, Inc. v. Sun Pharmaceutical Industries, Inc., No. 2:10-cv-14514 (BAF/MJH) (E.D. Mich.) (defense of patent infringement action relating to generic dexemdetomidine drug product)
- Tyco Healthcare Group LP, et al. v Mutual Pharmaceutical Co., Inc., et al., Civil Action No. 07-cv-1299 (D.N.J.) and Appeal No. 2010-1513 (Fed. Cir.) (obtained summary judgment of invalidity that asserted patent was obvious, which was affirmed by Federal Circuit)
- In re Gabapentin Patent Litigation, MDL No. 1384, Master Civil Action No. 00-2931 (D.N.J.) (patent infringement dispute involving gabapentin)
- Aventis Pharmaceuticals Inc., et al. v. Sun Pharma Global Inc., et al., Civil Action Nos. 09-cv-00325 & -05179; Civil Action No.: 2:09-cv-5179-JAG (D.N.J.) (patent infringement dispute involving fexofenadine and fexofenadine / pseudoephedrine products)
- Roche Palo Alto LLC. v. Endo Pharmaceuticals Inc., Civil Action No. 10-cv-00261-GMS (D. Del.) (patent infringement dispute involving valganciclovir hydrochloride)
- United States Gypsum Co. v. Lafarge North America, Inc., Lafarge S.A., et al., Civil Action No. 03-CV-6027 (N.D. Ill. 2003) (theft of confidential, proprietary and trade secret information and patent infringement involving gypsum drywall manufacturing)
- Pall Corp. v. Entegris, Inc., Civil Action No. 07-CV-1869 (E.D.N.Y. 2007) (infringement dispute concerning filter media packing and capsule design)
- Pall Corp. v. Entegris, Inc., Civil Action No. 05-CV-5894 (E.D.N.Y. 2005) (patent infringement dispute involving filter assembly methods and pre-wet packaging)
- Entegris, Inc. v. Pall Corp., Appeal Nos. 2004-1440, 2005-1265, -1266, 2006-1374 (Fed. Cir. 2006) (appeal from preliminary injunction and contempt order in patent infringement dispute concerning filter assembly)
- AstraZeneca AB, et al. v. Mutual Pharmaceutical Co., Inc., Appeal No. 04-1100 (Fed. Cir. 2004) (appeal in pharmaceutical case relating to generic extended-release felodipine tablets)
- Ciba Specialty Chemicals Corp. v. Zinkan Enterprises Inc., et al., Civil Action No. C2 03 174 (S.D. Ohio 2002) (patent infringement dispute involving treatment of wastewater from coal mining)
Honors
- Profiles in Diversity Journal Asian Leadership Award Winner (2023)
- New Leaders in the Law – Connecticut Law Tribune (2014)
News
- Jason Murata Named a Profiles in Diversity Journal Asian Leadership Award Winner
- Axinn’s Client Awarded Attorneys’ Fees in “Exceptional” PIV Case
- Axinn Named a "Legal Lion" for Federal Circuit Patent Win
- Axinn Launches California Office, Bringing Elite Antitrust and IP Practices to West Coast
- Axinn Promotes Jeny Maier and Jason Murata
- View More ›
Thought Leadership
- American Intellectual Property Law Association Featured Member, March 31, 2022
- Queer IP Attys Say It's Time to Break Down the L, G, B & T, Law360, December 7, 2021
- When Japanese Witnesses Testify in U.S. Courts: Answers to Nine Common Concerns, January 2021
- The 2020 Axinn Survey of U.S. Litigation Involving Japanese Companies, November 2020
- Inclusion Matters, Now More Than Ever: Practical Suggestions for Making a Difference, AIPLA Innovate Magazine, July 10, 2020
- Attorney-Client Privilege in the United States: Recent Trends in its Application to Japanese Patent Professionals, AIPPI Journal, April 2020
- The 2019 Axinn Survey of U.S. Litigation Involving Japanese Companies, March 2020
- Axinn Insights on U.S. Litigation for Japanese Companies: The Duty to Preserve Documents and Implement Litigation Holds in U.S. Civil Litigation, August 19, 2019
- 23andMe to Appeal to Federal Circuit in Spat With Ancestry.com, BioWorld MedTech, November 12, 2018
- Integrating Trade Secrets into a Comprehensive IP Strategy, Today's General Counsel, June 19, 2018
- How Much Detail Should You Provide in a Patent Infringement Complaint?, Intellectual Property Magazine, December 2016
- Recent Developments in Japanese and U.S. Trade Secret Laws, Business Law Journal, No. 104, November 2016
- How a Merck Attorney’s Lies Torpedoed a $200M Patent Verdict, Law360 In-Depth, June 13, 2016
- The Next AIA Battleground: IPR And Estoppel, Law360, May 26, 2016
- Twombly, Iqbal And The Demise Of Form 18, Law360, November 18, 2014
- Are Your Secrets Safe?, Risk Management, June 1, 2014
- Protecting Business Trade Secrets When Working Abroad, Hartford Business Journal, April 28, 2014
- IP Law: Trade Secrets And Patent Reform, The Connecticut Law Tribune, April 17, 2014
- Obviousness in Medical Device Patent Litigation, Corporate Counsel, September 16, 2013
Events
- LSPN North America Fall Conference 2023
- ACI 14th Annual Summit on Biosimilars & Innovator Biologics
- Trade Secret IP Protection & Management West Coast Summit
- AIPLA IP Practice in Japan Committee Pre-Meeting and Dinner
- Consero IP Forum for Life Sciences
- 2022 AIPPI World Congress
- ACI 13th Annual Summit on Biosimilars & Innovator Biologics
- Bay Area CHIZAI 43rd Seminar
- ACI 38th Annual FDA Boot Camp
- AIPLA DEI Program: Perspectives from LGBTQ Professionals
- Making DEI Policies “Systemic” – Global and National Approaches
- AIPLA Diversity in IP Law: Where Are We Now? The Progression of Diversity, Equity and Inclusion in the Face of a Global Pandemic and Racial Reckoning
- AIPLA Diversity Roundtable
- Improving the JPO and Intellectual Property Practices: Views From the JPO
- Joint Meeting: AIPLA and AIPPI Japan
- 2019 Centerforce IP Strategy Summit: Global & Domestic - Silicon Valley
- AIPLA IP Practice in Japan Committee Pre-Meeting and Dinner
- The On-Sale Bar After Helsinn
- ACI 9th Annual Summit on Biosimilars
- 35 U.S.C. 103 and the CAFC from District Courts
- Damages Under State Trade Secret Laws and The Defend Trade Secrets Act of 2016
- ACI 3rd Annual Post Grant PTO Proceedings Conference
- IP Practice in Japan Pre-Meeting: IPR Estoppels in Litigation
- Centerforce 4th Annual IP Strategy Summit - Silicon Valley
- IP Practice in Japan Pre-Meeting: Defend Trade Secrets Act
- Breaking Through "The Bamboo Ceiling"
- Trading in Secrets: Dealing with Employee and Data Mobility
Education
- JD – Washington University School of Law (2002)
- MA, Biology – Washington University (2002)
- BS, Biochemistry – McMaster University (1999)
Admissions
- California
- Connecticut
- Illinois
- New York
- US Court of Appeals for the Federal Circuit
- US District Court Northern District of Illinois
- US District Court Northern District of California